GlassScriptPhysician profile
Eve M Traill
NPI 1356331060
$1,867.99
in general payments reported to CMS, 2019-2025
17 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $58.09 · 2023: $726 · 2024: $703 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,545 · Education: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,544.92 |
| Education | $264.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $415.87 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $382.48 | 2023-2025 | |
| Novo Nordisk INC | $228.03 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $192.62 | 2023-2025 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $139.60 | 2022-2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $135.07 | 2023 | Seglentis, Livalo |
| Exact Sciences Corporation | $92.81 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $61.65 | 2023-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $43.52 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.82 | 2023-2024 | Trintellix |
| Sumitomo Pharma America, INC. | $34.51 | 2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $20.53 | 2025 | |
| Janssen Pharmaceuticals, INC | $19.82 | 2023 | Spravato |
| Axsome Therapeutics, INC. | $18.99 | 2025 | Auvelity |
| Ascendis Pharma Endocrinology INC | $15.84 | 2025 | Yorvipath |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $15.50 | 2023 | Nexplanon |
| Lundbeck LLC | $14.33 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eve Traill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.